MedPath

Assessing the Utility of Phototherapy Rompers in Kangaroo Mother Care, Feeding, and Natural Care Tasks

Not Applicable
Conditions
Health Condition 1: P599- Neonatal jaundice, unspecified
Registration Number
CTRI/2023/11/060348
Lead Sponsor
Dr R Lakshmipathy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Other (Terminated)
Sex
Not specified
Target Recruitment
1
Inclusion Criteria

Newborns at or above 35 weeks gestation with the pre discharge TSB level placing the newborn in high intermediate and low intermediate risk zone

parents or legal guardian who provide informed consent for their baby participation in the study

the parents of the neonate are able to provide kangaroo mother care and fee the baby as per instructions of the neonatologists

Exclusion Criteria

Newborns below 35 weeks gestation

Newborns with contraindications to phototherapy

Newborns with co morbidities other than hyperbilirubinemia

Parents or legal guardians who do not provide informed consent for their baby participation in the study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
sability assessment and user friendliness particularly during the kangaroo mother care and feedingTimepoint: During and end of study
Secondary Outcome Measures
NameTimeMethod
Incidence of adverse events related to the use of the phototherapy romper Other study parametersTimepoint: Baseline and End of study;?Adherence to using the phototherapy romper during kangaroo mother care and feeding periods.Timepoint: End of study;?Duration of phototherapy required to achieve clinically acceptable bilirubin levels for stopping phototherapy.Timepoint: End of study
© Copyright 2025. All Rights Reserved by MedPath